Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Share:

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 18.99%. Akorn's revenue for the same period is $227.26 million.

The trailing-twelve-month return on equity at Hi Tech Pharmacal Co (NASDAQ: HITK) is 18.38%. Hi Tech Pharmacal's operating margin for the same period is 24.58%.

The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ: SLXP) is 15.84%. Salix Pharmaceuticals had $775.90 million in total cash for the latest quarter.

The trailing-twelve-month return on equity at Mylan (NASDAQ: MYL) is 14.65%. Mylan's PEG ratio is 0.72.

Posted-In: Drugs-Generic Industry highest ROE NASDAQTrading Ideas

 

Related Articles (AKRX + HITK)

View Comments and Join the Discussion!
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Top 4 Stocks In The Information Technology Services Industry With The Highest Dividend Yield

Top 4 Large-Cap Stocks In The Business Services Industry With The Highest Revenue